← Oncology Approval Tracker

FDA DECISION ·

Pemetrexed for Injection (Hospira)

pemetrexed · Hospira

FDA approvalNew formulationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

An additional pemetrexed-for-injection product for labeled nonsquamous NSCLC uses and initial cisplatin combination treatment of unresectable or nonsurgical malignant pleural mesothelioma.

LAMPGEN ANALYSIS

Why it matters

The approval concerns an established antifolate supplied under a separate formulation application.

What research teams should watch

Check this product’s labeled partners, reconstitution and supplementation instructions before stocking.

PRIMARY RECORDS

Sources